These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16804994)

  • 1. [What opportunities are afforded by enzyme replacement therapy].
    Huppertz HI
    Z Rheumatol; 2006 Feb; 65(1):44-5. PubMed ID: 16804994
    [No Abstract]   [Full Text] [Related]  

  • 2. [Care in the treatment of orphan diseases at home].
    Bénévise N
    Soins; 2003; (672):49-51. PubMed ID: 12655827
    [No Abstract]   [Full Text] [Related]  

  • 3. The attenuated/late onset lysosomal storage disorders: Therapeutic goals and indications for enzyme replacement treatment in Gaucher and Fabry disease.
    Hollak CE; Weinreb NJ
    Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):205-18. PubMed ID: 25987174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High cost drugs for rare diseases in Brazil: the case of lysosomal storage disorders].
    de Souza MV; Krug BC; Picon PD; Schwartz IV
    Cien Saude Colet; 2010 Nov; 15 Suppl 3():3443-54. PubMed ID: 21120332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How does the landscape change in lysosomal storage disease].
    Parini R
    Pediatr Med Chir; 2007; 29(5):275-8. PubMed ID: 18402399
    [No Abstract]   [Full Text] [Related]  

  • 6. Lysosomal storage disorders: Novel and frequent pathogenic variants in a large cohort of Indian patients of Pompe, Fabry, Gaucher and Hurler disease.
    Thomas DC; Sharma S; Puri RD; Verma IC; Verma J
    Clin Biochem; 2021 Mar; 89():14-37. PubMed ID: 33301762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme therapy: problems and solutions.
    Holcenberg JS
    Annu Rev Biochem; 1982; 51():795-812. PubMed ID: 6810751
    [No Abstract]   [Full Text] [Related]  

  • 8. Enzyme replacement therapy in Gaucher's and Fabry's disease.
    Pentchev PG
    Ann Clin Lab Sci; 1977; 7(3):251-3. PubMed ID: 404951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enzyme replacement therapy for lysosomal storage disorders].
    Valayannopoulos V; Brassier A; Chabli A; Caillaud C; Lemoine M; Odent T; Arnoux JB; de Lonlay P
    Arch Pediatr; 2011 Oct; 18(10):1119-23. PubMed ID: 21873040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Shift of focus in the financing of Hungarian drugs. Reimbursement for orphan drugs for treating rare diseases: financing of enzyme replacement therapy in Hungary].
    Szegedi M; Molnár MJ; Boncz I; Kosztolányi G
    Orv Hetil; 2014 Nov; 155(44):1735-41. PubMed ID: 25344850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances and novel treatments for sphingolipidoses.
    Arenz C
    Future Med Chem; 2017 Sep; 9(14):1687-1700. PubMed ID: 28857617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme replacement for lysosomal diseases.
    Brady RO
    Annu Rev Med; 2006; 57():283-96. PubMed ID: 16409150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enzyme replacement therapy of lysosomal storage diseases].
    Germain DP; Boucly C; Carlier RY; Caudron E; Charlier P; Colas F; Jabbour F; Martinez V; Mokhtari S; Orlikowski D; Pellegrini N; Perronne C; Prigent H; Rubinsztajn R; Benistan K
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S279-91. PubMed ID: 21211680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme replacement therapy for lysosomal storage disorders: successful transition from concept to clinical practice.
    Sly WS
    Mo Med; 2004; 101(2):100-4. PubMed ID: 15119106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gaucher disease, Fabry disease and mucopolysaccharidosis type I--how can the rheumatologist recognise these patients?].
    Manger B; Menge E; Schaefer R; Haase C; Seidel J; Michels H
    Z Rheumatol; 2006 Feb; 65(1):32, 34-43. PubMed ID: 16467949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical chaperones--a new concept in drug research.
    Kolter T; Wendeler M
    Chembiochem; 2003 Apr; 4(4):260-4. PubMed ID: 12672104
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: Therapy in genetic disease.
    Erbe RW
    N Engl J Med; 1974 Nov; 291(19):1028-9. PubMed ID: 4213051
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigations in enzyme replacement therapy in lipid storage diseases.
    Brady RO; Pentchev PG; Gal AG
    Fed Proc; 1975 Apr; 34(5):1310-5. PubMed ID: 804420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous enzyme replacement therapy: better in home or hospital?
    Milligan A; Hughes D; Goodwin S; Richfield L; Mehta A
    Br J Nurs; 2006 Mar 23-Apr 12; 15(6):330-3. PubMed ID: 16628169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current enzyme replacement therapy for the treatment of lysosomal storage diseases.
    Lim-Melia ER; Kronn DF
    Pediatr Ann; 2009 Aug; 38(8):448-55. PubMed ID: 19725195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.